USD 3.35
(4.69%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 44.12 Million USD | -24.06% |
2022 | 58.1 Million USD | -58.5% |
2021 | 140 Million USD | 248.97% |
2020 | 40.11 Million USD | 42.26% |
2019 | 28.2 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 43.82 Million USD | -0.67% |
2024 Q2 | 45.89 Million USD | 4.72% |
2023 Q2 | 57.26 Million USD | -13.1% |
2023 Q3 | 42.3 Million USD | -26.13% |
2023 Q1 | 65.9 Million USD | 13.43% |
2023 FY | 44.12 Million USD | -24.06% |
2023 Q4 | 44.12 Million USD | 4.31% |
2022 Q3 | 80.68 Million USD | -20.82% |
2022 Q4 | 58.1 Million USD | -27.99% |
2022 FY | 58.1 Million USD | -58.5% |
2022 Q1 | 124.11 Million USD | -11.35% |
2022 Q2 | 101.9 Million USD | -17.9% |
2021 Q3 | 160.27 Million USD | 228.25% |
2021 FY | 140 Million USD | 248.97% |
2021 Q4 | 140 Million USD | -12.65% |
2021 Q2 | 48.82 Million USD | -78.88% |
2021 Q1 | 231.2 Million USD | 476.31% |
2020 FY | 40.11 Million USD | 42.26% |
2020 Q2 | 110 Thousand USD | 0.0% |
2020 Q3 | 231.74 Million USD | 210579.76% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 40.11 Million USD | -82.69% |
2019 FY | 28.2 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott Laboratories | 73.21 Billion USD | 99.94% |
Allurion Technologies Inc. | 71.71 Million USD | 38.472% |
Artivion, Inc. | 792.39 Million USD | 94.432% |
Avanos Medical, Inc. | 1.69 Billion USD | 97.393% |
Butterfly Network, Inc. | 304.27 Million USD | 85.499% |
Butterfly Network, Inc. | 304.27 Million USD | 85.499% |
Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 99.641% |
Boston Scientific Corporation | 35.13 Billion USD | 99.874% |
CONMED Corporation | 2.3 Billion USD | 98.082% |
Edwards Lifesciences Corporation | 9.36 Billion USD | 99.529% |
Paragon 28, Inc. | 340.69 Million USD | 87.049% |
Glaukos Corporation | 940.41 Million USD | 95.308% |
Globus Medical, Inc. | 5.08 Billion USD | 99.132% |
Inspire Medical Systems, Inc. | 676.81 Million USD | 93.481% |
Integer Holdings Corporation | 2.94 Billion USD | 98.501% |
Medtronic plc | 89.98 Billion USD | 99.951% |
Myomo, Inc. | 14.58 Million USD | -202.594% |
Nevro Corp. | 635.71 Million USD | 93.059% |
Penumbra, Inc. | 1.55 Billion USD | 97.165% |
Vicarious Surgical Inc. | 119.86 Million USD | 63.189% |
Smith & Nephew plc | 9.98 Billion USD | 99.558% |
Sonendo, Inc. | 78.16 Million USD | 43.548% |
STERIS plc | 11.06 Billion USD | 99.601% |
Stryker Corporation | 39.91 Billion USD | 99.889% |
Vapotherm, Inc. | 77.61 Million USD | 43.153% |
Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 99.795% |